ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RCPT (MM)

231.96
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
(MM) NASDAQ:RCPT NASDAQ Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 231.96 0.00 01:00:00

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Receptos, Inc.

20/07/2015 11:35am

Business Wire


RECEPTOS, INC. (NASDAQ:RCPT)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more RECEPTOS, INC. Charts.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Receptos, Inc. ("Receptos” or "the Company") (Nasdaq: RCPT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Celgene Corporation (“Celgene”).

Click here to learn more about the investigation http://brodsky-smith.com/964-rcpt-receptos-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Receptos shareholders will receive only $232.00 in cash for each share of Receptos stock they own. The investigation concerns whether the Board of Receptos breached their fiduciary duties to shareholders and whether Celgene is underpaying for Receptos. The transaction may undervalue the Company given Receptos has a strong pipeline which includes drug candidates for ulcerative colitis, Cohn’s disease, relapsing multiple sclerosis, inflammatory bowel disease, and eosinophilic esophagitis. Consequently, an analyst has set a price target for Receptos stock at $348.00 per share.

If you own shares of Receptos and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://brodsky-smith.com/964-rcpt-receptos-inc.html, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Brodsky & Smith, LLCJason L. Brodsky, EsquireEvan J. Smith, Esquire877-LEGAL-90http://brodsky-smith.com/964-rcpt-receptos-inc.html

1 Year RECEPTOS, INC. Chart

1 Year RECEPTOS, INC. Chart

1 Month RECEPTOS, INC. Chart

1 Month RECEPTOS, INC. Chart

Your Recent History

Delayed Upgrade Clock